These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11922568)

  • 21. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease.
    Suneetha PV; Sarin SK; Goyal A; Kumar GT; Shukla DK; Hissar S
    J Hepatol; 2006 May; 44(5):856-63. PubMed ID: 16545485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.
    Mueller T; Mas-Marques A; Sarrazin C; Wiese M; Halangk J; Witt H; Ahlenstiel G; Spengler U; Goebel U; Wiedenmann B; Schreier E; Berg T
    J Hepatol; 2004 Oct; 41(4):652-8. PubMed ID: 15464247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
    Suzuki F; Arase Y; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Satoh J; Kumada H
    J Viral Hepat; 2004 May; 11(3):271-6. PubMed ID: 15117331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV.
    Tokushige K; Tsuchiya N; Hasegawa K; Hashimoto E; Yamauchi K; Komatsu T; Hayashi N
    Am J Gastroenterol; 2003 Jan; 98(1):160-6. PubMed ID: 12526952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
    Bressler BL; Guindi M; Tomlinson G; Heathcote J
    Hepatology; 2003 Sep; 38(3):639-44. PubMed ID: 12939590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B.
    Murayama M; Katano Y; Nakano I; Ishigami M; Hayashi K; Honda T; Hirooka Y; Itoh A; Goto H
    J Med Virol; 2007 Jan; 79(1):35-40. PubMed ID: 17133546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity].
    Gervain J; Czibula A; Simon J; Kalmár T
    Orv Hetil; 2003 Jun; 144(24):1179-84. PubMed ID: 12866147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin.
    Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Hsieh MY; Hou NJ; Lin ZY; Hsieh MY; Wang LY; Yu ML
    Antiviral Res; 2005 Aug; 67(2):93-7. PubMed ID: 16051377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients.
    Bouzgarrou N; Hassen E; Gabbouj S; Schvoerer E; Ben Mami N; Triki H; Chouchane L
    Gastroenterol Clin Biol; 2010; 34(4-5):297-304. PubMed ID: 20537485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between the level of serum TNF-alpha of patients with chronic hepatitis C and treatment with interferon-alpha and the influencing factors].
    Ren Y; Duan ZH; Meng QH; Li Z; Li J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):129-31. PubMed ID: 20104757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor gene polymorphism in chronic sinusitis.
    Takeuchi K; Majima Y; Sakakura Y
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1711-4. PubMed ID: 11037831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor-α promoter gene polymorphisms are not associated with hepatitis C virus infection in Chinese hemodialysis patients.
    Zhang X; Hu D; Zhu B; Wang C; He J; Wu J; Yu RB; Zhao WH
    Ren Fail; 2011; 33(6):593-9. PubMed ID: 21631181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation.
    Rosen HR; Lentz JJ; Rose SL; Rabkin J; Corless CL; Taylor K; Chou S
    Transplantation; 1999 Dec; 68(12):1898-902. PubMed ID: 10628771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.
    Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M
    Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the simultaneous tumor necrosis factor receptor 2, tumor necrosis factor promoter gene polymorphism represent a higher risk for alcoholic liver disease?
    Machado MV; Martins A; Almeida R; Marques-Vidal P; Gonçalves MS; Camilo ME; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):201-5. PubMed ID: 19212208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of hepatitis C genotypes in Indian patients and their clinical significance.
    Amarapurkar D; Dhorda M; Kirpalani A; Amarapurkar A; Kankonkar S
    J Assoc Physicians India; 2001 Oct; 49():983-5. PubMed ID: 11848330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.